Acumen Pharmaceuticals Ownership | Who Owns Acumen Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Acumen Pharmaceuticals Ownership Summary


Acumen Pharmaceuticals is owned by 55.98% institutional investors, 7.03% insiders, and 36.99% retail investors. Ra capital management is the largest institutional shareholder, holding 24.65% of ABOS shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.44% of its assets in Acumen Pharmaceuticals shares.

ABOS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAcumen Pharmaceuticals55.98%7.03%36.99%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management14.93M24.65%$25.53M
Sands capital ventures3.42M5.64%$5.84M
Franklin resources2.31M3.81%$3.94M
Blackrock2.16M3.61%$5.22M
Fmr2.03M3.35%$3.47M
Vanguard group1.65M2.73%$2.82M
Knollwood investment advisory1.63M2.69%$2.78M
Millennium management1.14M1.88%$1.25M
Alyeska investment group939.60K1.55%$1.61M
Adar1 capital management891.18K1.47%$1.52M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sands capital ventures3.42M1.28%$5.84M
Ra capital management14.93M0.31%$25.53M
Knollwood investment advisory1.63M0.25%$2.78M
Adar1 capital management891.18K0.14%$1.52M
Ikarian capital265.77K0.05%$454.46K
Laurion capital management lp867.05K0.03%$1.48M
Intrepid financial planning group30.15K0.02%$51.56K
Catalyst financial partners89.70K0.02%$153.38K
Catalyst funds management pty29.60K0.01%$50.62K
Clune & associates16.50K0.01%$28.21K

Top Buyers

HolderShares% AssetsChange
Blackrock2.16M0.00%1.97M
Sg americas securities403.88K0.00%403.88K
Renaissance584.29K0.00%337.70K
Acadian asset management77.92K0.00%77.92K
Bridgeway capital management190.17K0.01%75.00K

Top Sellers

HolderShares% AssetsChange
Rock springs capital management lp---1.84M
Franklin resources2.31M0.00%-771.94K
Parkman healthcare partners---576.66K
Y-intercept (hong kong)---250.85K
Tang capital management---246.90K

New Positions

HolderShares% AssetsChangeValue
Acadian asset management77.92K0.00%77.92K$131.00K
Cubist systematic strategies23.90K0.00%23.90K$40.88K
Pfg investments11.50K0.00%11.50K$19.66K
Savant capital11.04K0.00%11.04K$18.89K
Larson financial group4.00K0.00%4.00K$6.84K

Sold Out

HolderChange
True wealth design-35.00
Capital performance advisors llp-52.00
Clearstead advisors-63.00
Russell investments group-278.00
Coldstream capital management-311.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202565-9.72%33,908,640-9.82%551.45%20-35.48%2712.50%
Jun 30, 202572-13.25%37,610,957-6.52%621.41%3119.23%24-29.41%
Mar 31, 20255-93.83%16,490,041-61.19%270.54%1-97.50%2-90.00%
Dec 31, 2024815.19%42,494,401-2.55%701.34%4017.65%20-4.76%
Sep 30, 202477-10.47%43,605,2660.06%721.37%34-24.44%2110.53%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Franklin Biotechnology Discv A(acc)USD1.48M2.44%-
Fidelity Select Health Care1.14M1.88%-
Vanguard Total Stock Mkt Idx Inv1.12M1.85%-24.52K
iShares Russell 2000 ETF971.80K1.60%-
Franklin Biotechnology Discovery A826.40K1.36%-
Franklin US Small Cap Growth Equity771.94K1.27%3.97K
Franklin Small Cap Growth SMA771.94K1.27%771.94K
Franklin Small Cap Growth Adv708.38K1.17%-59.59K
Fidelity Advisor Health Care I700.00K1.16%-
Fidelity Small Cap Index408.40K0.67%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 21, 2025Zuga Matt CFO & Chief Business OfficerSell$6.99K
Jan 23, 2025Zuga Matt CFO & Chief Business OfficerSell$49.63K
Jan 21, 2025OConnell Daniel Joseph Chief Executive OfficerSell$20.10K
Jan 21, 2025Meisner Derek M Chief Legal Officer & Corp SecSell$5.43K
Jan 21, 2025Barton Russell Chief Operating OfficerSell$4.69K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1-11
2024 Q4--
2024 Q2--
2024 Q1-5

ABOS Ownership FAQ


Who Owns Acumen Pharmaceuticals?

Acumen Pharmaceuticals shareholders are primarily institutional investors at 55.98%, followed by 7.03% insiders and 36.99% retail investors. The average institutional ownership in Acumen Pharmaceuticals's industry, Biotech Stocks , is 45.24%, which Acumen Pharmaceuticals exceeds.

Who owns the most shares of Acumen Pharmaceuticals?

Acumen Pharmaceuticals’s largest shareholders are Ra capital management (14.93M shares, 24.65%), Sands capital ventures (3.42M shares, 5.64%), and Franklin resources (2.31M shares, 3.81%). Together, they hold 34.10% of Acumen Pharmaceuticals’s total shares outstanding.

Does Blackrock own Acumen Pharmaceuticals?

Yes, BlackRock owns 3.61% of Acumen Pharmaceuticals, totaling 2.16M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.22M$. In the last quarter, BlackRock increased its holdings by 1.97M shares, a 1037.95% change.

Who is Acumen Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sands capital ventures is Acumen Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.28% of its assets in 3.42M Acumen Pharmaceuticals shares, valued at 5.84M$.

Who is the top mutual fund holder of Acumen Pharmaceuticals shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of Acumen Pharmaceuticals shares, with 2.44% of its total shares outstanding invested in 1.48M Acumen Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools